Working Together to Improve Health Services: A Focus on HIV, Hepatitis, NCDs, and Mental Health Read More
ICWEA Welcomes ViiV Healthcare’s Commitment to Triple Supply of Long-Acting HIV PrEP for Low- and Middle-Income Countries Read More
ICWEA Statement on Gilead Sciences’ Licensing of Lenacapavir: A Step Toward Expanding HIV Prevention Choices Read More
